SCHEMBL150760

SCHEMBL150760

CN(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+]

nearest known ligand 0.47

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA4 known ✓ P22748 4/20 0.42
CA2 known ✓ P00918 1/20 0.39
CA1 known ✓ P00915 4/20 0.39
KDM4E B2RXH2 1/20 0.42
MAPT P10636 1/20 0.42
ALOX15 P16050 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
FFAR3 O14843 2/20 0.41
HDAC3 O15379 2/20 0.41
HDAC1 Q13547 2/20 0.41
HDAC2 Q92769 2/20 0.41
HDAC8 Q9BY41 2/20 0.41
CASP1 P29466 1/20 0.40
BBOX1 O75936 2/20 0.37
CYP2C19 P33261 1/20 0.35
FAHD1 Q6P587 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30831235 0.94 BBOX1 (0.37) KDM4EMAPTALOX15SMN1; SMN2CA4
SCHEMBL29276294 0.94 CYP2C19 (0.41) KDM4EMAPTALOX15SMN1; SMN2CA4
SCHEMBL692963 0.94 BBOX1 (0.37) KDM4EMAPTALOX15SMN1; SMN2CA4
Potassium Ion SCHEMBL434991 0.94 BBOX1 (0.37) KDM4EMAPTALOX15SMN1; SMN2CA4
SCHEMBL31636033 0.89 KDM4E (0.37) KDM4EMAPTALOX15SMN1; SMN2CA4
SCHEMBL28432505 0.87 KDM4E (0.35) KDM4EMAPTALOX15SMN1; SMN2CA4
SCHEMBL1616806 0.81
Potassium Ion SCHEMBL4411096 0.80
SCHEMBL60547 0.79
Hydrochloric Acid SCHEMBL4354105 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119346163-B Preparation method and application of rare earth-based copper molecular sieve denitration catalyst resistant to alkali metal poisoning 包头稀土研究院 2025-06-13 CN claimed
CN-119346163-A Preparation method and application of rare earth-based copper molecular sieve denitration catalyst resistant to alkali metal poisoning 包头稀土研究院 2025-01-24 CN claimed
EP-0514169-B1 Process for recovering N-methyliminodiacetic acid from sodium sulfate solutions HAMPSHIRE CHEMICAL CORP (US) 1995-12-20 EP claimed
EP-0514169-A2 Process for recovering N-methyliminodiacetic acid from sodium sulfate solutions HAMPSHIRE CHEMICAL CORPORATION (US) 1992-11-19 EP claimed
US-5159110-A Acidification, dehydration to crystallize sodium sulfate, separation W. R. GRACE & CO.-CONN. (US) 1992-10-27 US claimed
US-4279769-A COLORFASTNESS KAO SOAP CO., LTD. (JP) 1981-07-21 US claimed
CN-119346163-B Preparation method and application of rare earth-based copper molecular sieve denitration catalyst resistant to alkali metal poisoning 包头稀土研究院 2025-06-13 CN disclosed
CN-119240732-B Rare earth molecular sieve and preparation method and application thereof 包头稀土研究院 2025-06-13 CN disclosed
CN-119346163-A Preparation method and application of rare earth-based copper molecular sieve denitration catalyst resistant to alkali metal poisoning 包头稀土研究院 2025-01-24 CN disclosed
CN-119240732-A Rare earth molecular sieve and preparation method and application thereof 包头稀土研究院 2025-01-03 CN disclosed
US-9732102-B2 System for controlling the reactivity of boronic acids THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-08-15 US disclosed
US-20170002026-A1 System for Controlling the Reactivity of Boronic Acids THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2017-01-05 US disclosed
US-9328127-B2 System for controlling the reactivity of boronic acids THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-05-03 US disclosed
US-5171770-A Includes benzotriazle derivtives, hindered amines and compound containing at least one tertiary nitrogen atom and at least one metal carboxylate group POLYPLASTICS CO., LTD. (JP) 1992-12-15 US disclosed
EP-0496638-A2 Stabilized polyoxymethylene resin composition POLYPLASTICS CO. LTD. (JP) 1992-07-29 EP disclosed
US-5128405-A Preventing depolymerization POLYPLASTICS CO., LTD. (JP) 1992-07-07 US disclosed
EP-0492974-A2 Stabilized polyoxymethylene resin composition POLYPLASTICS CO. LTD. (JP) 1992-07-01 EP disclosed
EP-0435649-A1 Polyoxymethylene composition POLYPLASTICS CO. LTD. (JP) 1991-07-03 EP disclosed
EP-0411867-A1 Weather-resistant polyacetal resin compositions and weather-resistant molded articles formed thereof POLYPLASTICS CO. LTD. (JP) 1991-02-06 EP disclosed
US-4279769-A COLORFASTNESS KAO SOAP CO., LTD. (JP) 1981-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170002026-A1 System for Controlling the Reactivity of Boronic Acids ORC3, BRS3, OSBPL3 CA4 153/4885CA2 415/4885CA1 647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.